A team of Cardiff University scientists has identified a key protein in the blood that prevents chemotherapy killing leukaemia cells. It is believed the new research is another step forward in the School’s ongoing exploration of better treatments for chronic lymphocytic leukaemia, the most common form of leukaemia in the Western world. Chronic lymphocytic leukaemia is an incurable and slowly progressing blood cancer, characterised by a build up of malignant cells in the patient’s blood. (source: cardiff.ac.uk)
|